Quantcast

Garden State Times

Saturday, September 21, 2024

FDA Inspection: What type of New Jersey companies were under most scrutiny during Q2 2023?

Webp feai7bphhdls0aqws5mfv0zinhxh

Dr. Christine S. Lee Acting Associate Commissioner for Minority Health and Director of the Office of Minority Health and Health Equity (OMHHE) in the Office of the Commissioner at the U.S. FDA | Official Website

Dr. Christine S. Lee Acting Associate Commissioner for Minority Health and Director of the Office of Minority Health and Health Equity (OMHHE) in the Office of the Commissioner at the U.S. FDA | Official Website

In the second quarter of 2023, 56 Food and Cosmetics companies received 58 FDA inspections in New Jersey, according to the U.S. Food and Drug Administration (FDA).

This was the highest number of inspections per type of company made by the FDA in New Jersey, equalling 69% of all inspections in the second quarter of 2023.

Of all the New Jersey companies involved in the Food and Cosmetics sector, Indian Foods & Spices, LLC, Family Food Distributors, Inc., and International Coconut Corporation received the most citations from the FDA in the second quarter of 2023.

The FDA routinely inspects facilities across the nation to determine if the workplaces and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly for businesses to consistently make smarter business decisions for the future.

The FDA is a government agency primarily responsible for monitoring the manufacturing and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.

Top 10 FDA Inspections by Number of Actions Indicated in New Jersey During Q2 2023
Project AreaNo Action IndicatedVoluntary Action IndicatedOfficial Action Indicated
Bioresearch Monitoring4----
Blood and Blood Products2----
Colors and Cosmetics Technology1----
Compliance: Devices15--
Drug Quality Assurance36--
Food Composition, Standards, Labeling and Econ131--
Foodborne Biological Hazards3219--
Human Cellular, Tissue, and Gene Therapies11--
Monitoring of Marketed Animal Drugs, Feed, and Devices31--
Postmarket Assurance: Devices3----

MORE NEWS